Last updated on November 2017

Safety, PK and Effectiveness of IV Peramivir in Elderly and Higher Risk Subjects With Uncomplicated Influenza


Brief description of study

Safety, PK and Effectiveness of IV Peramivir in Elderly and Higher Risk Subjects With Uncomplicated Influenza

Detailed Study Description

This study will evaluate the safety, pharmacokinetics and effectiveness of a single dose of 600 mg IV peramivir in the treatment of elderly subjects with acute uncomplicated influenza infection and in subjects with acute uncomplicated influenza infection at higher risk for influenza complications. All subjects will receive IV peramivir.

Clinical Study Identifier: TX7953

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Arais Quinones

Advanced Pharma - Miami
Miami, FL USA
  Connect »